Fennec Pharmaceuticals (FENC) SEC Filings & 10K Form

$6.98
-0.36 (-4.90%)
(As of 05/15/2024 ET)

Recent Fennec Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/14/2024
4:24 PM
Fennec Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2024
3:42 PM
Fennec Pharmaceuticals (Filer)
Form DEF 14A
05/02/2024
3:59 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2024
3:15 PM
Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
Form 4/A
04/22/2024
6:34 PM
Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
3:21 PM
Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/18/2024
8:43 PM
Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2024
3:24 PM
Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/17/2024
3:23 PM
Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/16/2024
5:00 PM
Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
3:15 PM
Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/15/2024
5:15 PM
Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
3:28 PM
Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/05/2024
3:19 PM
Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/04/2024
3:46 PM
Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/03/2024
4:37 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
3:55 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
4:00 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
3:14 PM
Fennec Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/27/2024
3:22 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
3:24 PM
Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
RALLIS CHRIS A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
3:43 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2024
6:31 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
3:05 PM
Fennec Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2024
2:53 PM
Fennec Pharmaceuticals (Filer)
Form 424B7
01/05/2024
4:24 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
3:45 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/04/2024
3:42 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/29/2023
3:30 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
2:51 PM
Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/17/2023
11:15 PM
Fennec Pharmaceuticals (Filer)
Form EFFECT
12/05/2023
7:51 PM
Fennec Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2023
8:20 PM
Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2023
3:52 PM
Fennec Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/09/2023
3:56 PM
Fennec Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/08/2023
5:19 PM
Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2023
6:38 PM
Fennec Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2023
4:19 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
4:00 PM
Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
3:37 PM
Fennec Pharmaceuticals (Subject)
RALLIS CHRIS A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2023
9:51 AM
Fennec Pharmaceuticals (Filer)
Form 8-K/A
Wall Street legend who predicted 2021 tech crash issues new warning (Ad)

People around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly accurate stock predictions. And he just issued an urgent WARNING for some of the most popular stocks in U.S. history.

Watch his stock warning right here, 100% free of charge
08/04/2023
9:57 AM
Fennec Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/04/2023
9:58 AM
Fennec Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2023
4:04 PM
Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
4:20 PM
Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2023
4:08 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/30/2023
3:21 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2023
4:45 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/13/2023
11:39 AM
Fennec Pharmaceuticals (Issuer)
Islam Khalid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
10:42 AM
Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
10:47 AM
Cook Jodi A (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
9:45 AM
Brughera Marco Maria (Reporting)
Fennec Pharmaceuticals (Issuer)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
9:22 AM
Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2023
3:41 PM
Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:FENC) was last updated on 5/15/2024 by MarketBeat.com Staff

From Our Partners